©Author(s) (or their employer(s)) 2026.
World J Gastroenterol. Mar 14, 2026; 32(10): 116128
Published online Mar 14, 2026. doi: 10.3748/wjg.v32.i10.116128
Published online Mar 14, 2026. doi: 10.3748/wjg.v32.i10.116128
Table 2 Clinical data from patients with celiac disease, siblings of celiac disease patients and healthy subjects (control group), n (%)
| Variable | Category of variable | CeD, n = 14 | Siblings of CeD, n = 16 | Control group, n = 19 | P value1 | P value1,2 | P value1,3 | P value1,4 |
| Sex | Female | 7 | 7 | 16 | 0.033a | 0.752 | 0.045a | 0.045a |
| Male | 7 | 9 | 3 | |||||
| DQ2.2 | Positive | 4 (28.6) | 4 (25) | 3 (15.8) | 0.655 | |||
| Negative | 10 (71.4) | 12 (75) | 16 (84.2) | |||||
| DQ2.5 | Positive | 14 (100) | 8 (50) | 3 (15.8) | < 0.001a | 0.031a | < 0.05 | 0.071 |
| Negative | 0 (0.0) | 8 (50) | 16 (84.2) | |||||
| DQ8 | Positive | 1 (7.1) | 1 (6.3) | 6 (31.6) | 0.071 | |||
| Negative | 13 (92.9) | 15 (93.8) | 13 (68.4) |
- Citation: Salamon D, Krawczyk A, Zapała B, Duplaga M, Kowalska-Duplaga K, Gosiewski T. Gut bacterial and fungal signatures in relation to human leukocyte antigen-DQ2/DQ8 in children with celiac disease and siblings. World J Gastroenterol 2026; 32(10): 116128
- URL: https://www.wjgnet.com/1007-9327/full/v32/i10/116128.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i10.116128